# Prospective Study: TXA, Anticoagulant, Orthopaedic Trauma

> **NCT07116395** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Arbi Nazarian, MD** · enrollment: 200 (estimated)

## Conditions studied

- Patients Undergoing Operative Fixation of Long Bone Fractures Within the Community Medical Centers System

## Interventions

- **DRUG:** Tranexamic Acid (TXA)

## Key facts

- **NCT ID:** NCT07116395
- **Lead sponsor:** Arbi Nazarian, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2029-06-30
- **Final completion:** 2030-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07116395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07116395, "Prospective Study: TXA, Anticoagulant, Orthopaedic Trauma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07116395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*